Analyst Reco. AstraZeneca PLC Nasdaq

Equities

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-17 pm EDT			5-day change	1st Jan Change
76.9 ^USD	-0.18%		-0.36%	+14.18%

May. 17	Pfizer wins $107.5 million from AstraZeneca in US cancer drug patent trial	RE
May. 16	AstraZeneca's Sipavibart Prevents COVID-19 in Immunocompromised Patients in Phase 3 Trial	MT

ASTRAZENECA : UBS reiterates its Sell rating	May. 15	ZD
ASTRAZENECA : Buy rating from JP Morgan	May. 14	ZD
Jefferies Lifts AstraZeneca PT, Maintains Hold Rating	May. 08	MT
ASTRAZENECA : Jefferies sticks Neutral	May. 08	ZD
UBS raises Centrica to 'buy' from 'neutral	May. 08	AN
Berenberg Raises AstraZeneca PT, Keeps Rating at Buy	May. 07	MT
ASTRAZENECA : Berenberg keeps its Buy rating	May. 07	ZD
AstraZeneca target raised; Antofagasta lowered	May. 07	AN
ASTRAZENECA : Deutsche Bank gives a Neutral rating	Apr. 30	ZD
ASTRAZENECA : JP Morgan maintains a Buy rating	Apr. 29	ZD
Deutsche Bank likes Frasers; Barclays cuts JD	Apr. 29	AN
ASTRAZENECA : DZ Bank sticks Neutral	Apr. 26	ZD
ASTRAZENECA : UBS keeps a Sell rating	Apr. 26	ZD
ASTRAZENECA : Deutsche Bank remains Neutral	Apr. 26	ZD
ASTRAZENECA : Gets a Buy rating from Barclays	Apr. 26	ZD
Barclays Raises AstraZeneca PT, Affirms at Overweight	Apr. 26	MT
Peel Hunt cuts ConvaTec to 'reduce'	Apr. 26	AN
ASTRAZENECA : Strong Q1 raises hopes of a guidance upgrade	Apr. 25
ASTRAZENECA : UBS maintains a Sell rating	Apr. 25	ZD
ASTRAZENECA : Jefferies sticks Neutral	Apr. 25	ZD

No results for this search

ASTRAZENECA : Strong Q1 raises hopes of a guidance upgrade

April 25, 2024 at 12:02 pm EDT